Correlation of in vitro infiltration with glioma histological type in organotypic brain slices

British Journal of Cancer

Volumn 91, Issue 4, 2004, Pages 745-752

  Palfi, S ^a,b   Swanson, K R ^c   De Bouard S ^a   Chretien F ^a,b   Oliveira, R ^a   Gherardi, R K ^a,b   Kros, J M ^d   Peschanski, M ^a   Christov, C ^a,b  

^a INSERM   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c UNIVERSITY OF WASHINGTON   (United States)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Glioma; Invasion; Organotypic brain slice cultures

Indexed keywords

ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTOMA; BRAIN SLICE; CANCER GRADING; CANCER INFILTRATION; CANCER INVASION; CELL PROLIFERATION; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME DELETION; CHROMOSOME LOSS; CONTROLLED STUDY; CORRELATION ANALYSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; OLIGODENDROGLIOMA; PHENOTYPE; PRIORITY JOURNAL; RODENT; TUMOR BIOPSY;

EID: 4344566775     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602048     Document Type: Article

References (38)

1. Bigner SH, Matthews MR, Rasheed BK, Wiltshire RN, Friedman HS, Friedman AH, Stenzel TT, Dawes DM, McLendon RE, Bigner DD (1999) Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridisation. Am J Pathol 155: 375-386
2. Burgess PK, Kulesa PM, Murray JD, Alvord EC (1997) The interaction of growth rates and diffusion coefficients in a three-dimensional mathematical model of gliomas. J Neuropathol Exp Neurol 56: 704-713
3. Chicoine MR, Silbergeld DL (1995) The in vitro motility of human gliomas increases with increasing grade of malignancy. Cancer 75: 2904-2909
4. de Boüard S, Christov C, Guillamo JS, Kassar-Duchossoy L, Palfi S, Masset M, Cohen-Hagenauer O, Peschanski M, Lefrançois T (2002) Ivasion of human glioma biopsies in rodent brain slices: a quantitative analysis. J Neurosurg 97: 169-176
5. Deckert M, Reifenberger G, Wechsler W (1989) Determination of the proliferative potential of human brain tumours using the monoclonal antibody Ki-67. J Cancer Res Clin Oncol 115: 179-188
6. Donahue B, Scott CB, Nelson JS, Rotman M, Murray KJ, Nelson DF, Banker FL, Earle JD, Fischbach JA, Asbell SO, Gaspar LE, Markoe AM (1997) Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02. Int J Radiat Oncol Biol Phys 38: 911-914
7. Fallon KB, Palmer CA, Roth KA, Nabors LB, Wang W, Carpenter M, Banerjee R, Forsyth P, Rich K, Perry A (2004) Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas. J Neuropathol Exp Neurol 63: 314-322
8. Fuller CE, Schmidt RE, Roth KA, Burger PA, Scheithauer BW, Banerjee R, Trinkaus K, Lytle R, Perry A (2003) Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features. J Neuropathol Exp Neurol 62: 1118-1128
9. Geiger KD, Stoldt P, Schlote W, Derouiche A (2000) Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumours but is absent in oligodendrogliomas. Am J Pathol 157: 1785-1793
10. Giese A, Bjerkvig R, Berens ME, Westphal M. (2003) Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21: 1624-1636
11. Giese A, Loo MA, Tran N, Haskett D, Coons SW, Berens ME (1996) Dichotomy of astrocytoma migration and proliferation. Int J Cancer 67: 275-282
12. Gordower L, Decaestecker C, Lopez M-B, Camby I, Nagy N, François C, Cras P, Martin J-J, Brotchi J, Kisss R, Salmon I (1998) Determination of the growth fraction and cell density to evaluate the potential growth of human oligodendroglial and astrocytic tumours. J Cancer Res Clin Oncol 124: 427-434
13. Guillamo JS, Lisovoski F, Christov C, Le Guerinel C, Defer GL, Peschanski M, Lefrancois T (2001) Migration pathways of human glioblastoma cells xenografted into the immunosuppressed rat brain. J Neurooncol 52: 205-215
14. Heesters MA, Koudstaal J, Go K, Molenaar WM (1999) Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value. J Neurooncol 44: 226-255
15. Heesters MA, Koudstaal J, Gwan Go K, Molenaar WM (2002) Proliferation and apoptosis in long term surviving low grade gliomas in relation to radiotherapy. J Neurooncol 58: 157-165
16. Joy AM, Beaudry CE, Tran NL, Ponce FA, Holz DR, Demuth T, Berens ME (2003) Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis. J Cell Sci 116: 4409-4417
17. Jung S, Ackerley C, Ivanchuk S, Monda S, Becker LE, Rutka JT (2001) Tracking the invasiveness of human astrocytoma cells by using green fluorescent protein in an organorypical brain slice model. J Neurosurg 94: 80-89
18. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T (1994) Ki-67 immunoreactivity in human central nervous system tumours: a study with MIB 1 monoclonal antibody on archival material. Acta Neuropathol (Berl) 87: 47-54
19. Karim AB, Maat B, Hatlevoll R, Menten J, Rutten EH, Thomas DG, Mascarenhas F, Horiot JC, Parvinen LM, van Reijn M, Jager JJ, Fabrini MG, van Alphen AM, Hamers HP, Gaspar L, Noordman E, Pierart M, van Glabbeke M (1996) A randomized trial on dose - response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 36: 549-556
20. Kelly PJ, Daumas-Dupor C, Scheithauer BW, Kal BA, Kispert DB (1987) Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defmed abnormalities in patients with glial neoplasms. Mayo Clin Proc 62: 450-459
21. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumours of the nervous system. J Neuropathol Exp Neurol 61: 215-225
22. Kraus JA, Lamszus K, Glesmann N, Beck M, Wolter M, Sabel M, Krex D, Klockgether T, Reifenberger G, Schlegel U (2001) Molecular genetic alterations in glioblastomas with oligodendroglial component. Acta Neuropathol (Berl) 101: 311-320
23. Kraus JA, Wenghoefer M, Schmidt MC, von Deimling A, Berweiler U, Roggendorf W, Diete S, Dietzmann S, Müller B, Heuser K, Reifenberger G, Schlegel U (2000) Long-term survival of glioblastoma multiforme: importance of histopathological reevaluation. J Neurol 247: 455-460
24. Louis DN, Holland EC, Cairncross JG (2001) Glioma classification: a molecular reappraisal. Am J Pathol 159: 779-786
25. Mariani L, Beaudry C, McDonough WS, Hoelzinger DB, Demuth T, Ross KR, Berens T, Coons SW, Watts G, Trent JM, Wei JS, Giese A, Berens ME (2001) Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis. J Neurooncol 53: 161-176
26. McKeown MJ, Ramsay DA (1996) Classification of astrocytomas and malignant astrocytomas by principal components analysis and a neural net. J Neuropathol Exp Neurol 55: 1238-1245
27. Murakami M, Goto S, Yoshikawa M, Goto T, Hamasaki T, Rutka JT, Kuratsu JI, Ushio Y (2001) The invasive features of glial and non-central nervous system tumour cells are different on organotypic brain slices from newborn rats. Int J Oncol 18: 717-721
28. Rhodes RH (1998) Biological evaluation of biopsies from adult cerebral astrocytomas: cell-growth/cell-suicide ratios and their relationship to patient survival. J Neuropathol Exp Neurol 57: 746-757
29. Sasaki H, Zlatescu MC, Betensky RA, Johnk LB, Cutone AN, Cairncross JG, Louis DN (2002) Histopathological - molecular genetic correlations in referral pathologist-diagnosed low-grade 'oligodendroglioma'. J Neuropathol Exp Neurol 61: 58-63
30. Schiffer D, Cavalla P, Migheli A, Chio A, Giordana MT, Marino S, Attanasio A (1995) Apoptosis and cell proliferation in human neuroepithelial tumours. Neurosci Lett 195: 81-84
31. Schiffer D, Fiano V, Chiado-Piat L, Mortara P, Richiardi P, Cavalla P (2001) Distribution of activated caspase-3 in relation with apoptosis in human malignant gliomas. Neurosci Lett 300: 37-40
32. Silbergeld DL, Chicoine MR (1997) Isolation and characterization of human malignant glioma cells from histologically normal brain. J Neurosurg 86: 525-531
33. Swanson KR, Alvord Jr EC, Murray JD (2000) A quantitative model for differential motility of gliomas in grey and white matter. Cell Prolif 33: 317-329
34. Swanson KR, Alvord Jr EC, Murray JD (2002) Virtual brain tumours (gliomas) enhance the reality of medical imaging and highlight inadequacies of current therapy. Br J Cancer 86: 14-18
35. UKCCR (1998) United Kingdom Co-ordinating Committee on Cancer Research guidelines for the welfare of animals in experimental neoplasia, 2nd edn. Br J Cancer 77: 1-10
36. van den Bent MJ, Looijenga LH, Langenberg K, Dinjens WNM, Graveland WJ, Uytdewilligen L, Sillevis Smith PAE, Jenkins RB, Kros JM (2003) Chromosomal anomalies in oligodendroglial tumours are correlated to clinical features. Cancer 97: 1276-1284
37. Watanabe T, Nakamura M, Kros JM, Burkhard C, Yonekawa Y, Kleihues P, Ohgaki H (2002) Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas. Acta Neuropathol (Berl) 103: 267-275
38. British Journal of Cancer (2004) 91, 753-759